Health Programme DataBase - European Commission

Public Health / Projects

3rd Health Programme (2014-2020)

EPHA Operating Grant Proposal 2016 SGA [EPHA SGA 2016]

The Annual Work Programme for 2016 of EPHA is drawn from the multiannual work programme 2015-2017 and builds on successes to date. EPHA’s activities in 2016 will continue to contribute to all four objectives of the Third Health Programme. EPHA has formally reviewed our Strategic Plan 2011-2015. We undertook a thorough consultation process involving Board members, Staff and the EPHA membership, and an analysis of EPHA’s operating environment, strengths and weaknesses. The EPHA membership formally approved the new Strategic Plan 2016-2020 at the Annual General Assembly on 4th September 2015. The Work Programme for 2016 reflects the revised strategy to define a clearer selection of priorities. This approach will enable EPHA to manage activities more effectively, encourage closer cooperation between members and across themes, and better monitor and evaluate our impact.EPHA’s overarching strategic objective remains: “To promote good health and wellbeing, to reduce disease and health inequalities in European policies and programmes”. Priorities selected are as follows:Under Aims 1 and 2 of the 3rdHP and EPHA Strategic Objective “Securing a Governance for Health Approach in Key EU Policies” (HiAP):- Agriculture and Food Policy including Alcohol, Tobacco and NCDs- EU Semester for Health- Healthy Trade Policy- Public Health and Research in the EU BudgetUnder Aims 3 and 4 of the 3rdHP and EPHA Strategic Objective “Strengthen EU Policies to Reduce Health Inequalities and Ensure Universal Access to Sustainable, Inclusive Health Systems”:- Universal and Fair Access to Medicines- Action on Antimicrobial Resistance- Inclusive E- and M-Health- HSPAEach of these areas has operational objectives, milestones, deliverables and impact indicators. The Work Programme 2016 also highlights organisational development objectives, particularly on cooperation with academia, communications and financial sustainability, which are priorities for 2016.

Start date: 01/01/2016 - End date: 31/12/2016

Keywords : [ Amr ] [ Anthrax ] [ Anthrax ] [ Blood ] [ Botulism ] [ Breast ] [ Brucellosis ] [ Campylobacteriosis ] [ Cancer ] [ Cardiovascular Diseases ] [ Cervical ] [ Chlamydia ] [ Cholera ] [ Chronic Diseases ] [ Chronic Diseases ] [ Chronic kidney diseases ] [ Chronic pulmonary diseases ] [ Colorectal ] [ Communicable Diseases ] [ Communicable Diseases ] [ Cryptosporidiosis ] [ Dengue fever ] [ Diabetes ] [ Diphtheria ] [ Diseases of zoonotic and environmental origin and vector borne ] [ E ] [ E/M-Health ] [ Echinococcosis ] [ Economic Policy ] [ Emergent pathogens ] [ Epilepsy ] [ Food and waterborne diseases ] [ Giardisasis ] [ Gonorrhea ] [ HIV, STIs & Blood borne infections ] [ Health Research ] [ Healthcare-associated infections ] [ Hepatitis A ] [ Hepatitis B ] [ Hepatitis C ] [ Hiap ] [ Hiv/Aids ] [ Hpv ] [ Hspa ] [ Hspa. ] [ Influenza ] [ Invasive Haemophilus influenzae disease ] [ Invasive pneumococcal disease ] [ Ischaemic heart disease ] [ Legionnaire's diseaese ] [ Leptospirosis ] [ Leptospirosis ] [ Listeriosis ] [ Lung ] [ M-Health ] [ Malaria ] [ Measles ] [ Menongoccal disease ] [ Multiple sclerosis ] [ Mumps ] [ Musculo skeletal conditions ] [ Ncds ] [ Neurological diseases and disorders ] [ Other specific diseases ] [ Parkinson's disease ] [ Participation ] [ Plague ] [ Polio ] [ Prevention ] [ Prevention ] [ Promotion ] [ Protection ] [ Public Health ] [ Qfever ] [ Rabies ] [ Respiratory tract infections ] [ Rubella ] [ SARS ] [ Salmonellosis ] [ Shigellosis ] [ Shigellosis ] [ Smallpox ] [ Stomach ] [ Stroke ] [ Syphilis ] [ Tetanus ] [ Toxoplasmosis ] [ Trade ] [ Trichinellosis ] [ Tuberculosis ] [ Tularaemia ] [ Tularemia ] [ Type I ] [ Typhoid fever ] [ Universal Access ] [ VTEC ] [ Vaccine-preventable diseases ] [ Variant Creutzfeld-Jakob disease ] [ Viral Haemorrhagic fevers ] [ West Nile fever ] [ Yellow fever ] [ Yersiniosis ] [ campylobacteriosis ] [ pertussis ] [ prostate ] [ salmonellosis ] [ skin ] [ type II ]

Call: Health Programme Adhoc Call for invited (named) beneficiaries

Topic: Public Health

3rd Health Programme (2014-2020)

Bridging the gaps for a united Europe to denormalise tobacco use [ENSP FY 2017]

Compared to the rest of the world, the WHO European Region has one of the highest proportions of deaths attributable to tobacco. Eurobarometer 429/2015 indicates that almost one third of European citizens currently smoke, including cigarettes, cigars and pipes. The highest rates of tobacco consumption were found in Southern countries such as Greece (38%) and in Bulgaria (35%), while Nordic states have the lowest rates, with only 11% in Sweden and 19% in Finland. The rate of tobacco use differs substantially from one country to another, not only according to people’s level of education, income and occupation but also country of residence. This means that European citizens are facing the harsh reality of health inequalities, not only at national level but also at European level. Within this intricate context, ENSP is determined in 2017 to work at local and national levels to tackle the inequalities that are linked to tobacco use, and more specifically supporting countries that are lagging behind in implementing the TPD 2014/40/EU and WHO FCTC. With activities based on three main pillars: “Research, Prevention and Treatment”, ENSP is determined to: 1. Reduce the demand for tobacco products by tackling illicit trade; 2. Prevent young people from taking up by challenging targeted marketing and encourage tax increase; 3. Contribute to tobacco-related scientific research; 4. Facilitate the provision for tobacco dependence treatment. With exhaustive communication, the 2017 activities will be instrumental to the denormalisation of tobacco in Europe. While it will continue to work at European level with the Parliament, the European Commission and other Brussels-based and international partners to advocate for tobacco control focus policies and activities (f.e. revision of Directive 2011/64/EU on excise duties), ENSP is committed to support EU Member States as well as neighboring countries at national level, providing them with specific tailored support and leadership.

Start date: 01/01/2017 - End date: 31/12/2017

Keywords : [ 2014 ] [ Eu Directive 40 ] [ Eu Directive 40/2014 ] [ Network ] [ Public Health ] [ Tobacco Control ]

Call: Financial contribution to the functioning of non-governmental bodies (Operating grants)

Topic: Public Health

3rd Health Programme (2014-2020)

Smoking Prevention in Action: Smoke Free Partnership Coalition Operating Grant 2017 [SFP SGA 2017]

The overarching goal of the SFP Coalition’s multi-annual work programme is to improve the health of EU citizens and reduce health inequalities by promoting smoking prevention at EU and Member State level with a special focus on measures that prevent the uptake of smoking by young people.
The work plan for 2017 will conclude the 3-year cycle of activities planned in the FPA 2015-2017 while preparing the ground for a new cycle of activities. In 2017 the main priorities will be to coordinate the civil society response to the Tobacco Tax Directive review, to promote tobacco control policy research on the political agenda, and to continue exposing and countering tobacco industry interference in policy making across all tobacco control policy areas .

Start date: 01/01/2017 - End date: 31/12/2017

Keywords : [ Advocacy ] [ Prevention ] [ Prevention ] [ Public Health ] [ Tobacco Control ]

Call: Financial contribution to the functioning of non-governmental bodies (Operating grants)

Topic: Public Health

3rd Health Programme (2014-2020)

THALassaemia In Action 2018 [THALIA2018]

Thalassaemia, a previously fatal childhood genetic disease, can today be effectively prevented and appropriately treated, as a result of medical and scientific advances in the last three decades. However, thalassaemia’s prioritisation on national health agendas and the development of national plans for its effective control in the EU has been hampered by the many challenges involved, mainly related to its rarity and migration.

THALassaemia In Action 2018 (THALIA2018) focuses on Europe, targeting patients with thalassaemia and other haemoglobinopathies, healthcare professionals and policymakers and aims to attain four general objectives, based on TIF’s main pillars of activities:

1. Continue and strengthen the education of patients/parents and healthcare professionals, as well as the patients’ capacity, competency and networking within and across countries and regions of Europe. This is to be achieved via the development of e-learning tools and the launching of capacity building courses and training seminars.

2. Raise awareness on thalassaemia and the importance of optimal care amongst the public at large, as well as among THALIA target groups at national and European level. This will be attained using an array of online tools, activities and publications.

3. Prioritise haemoglobin disorders and their control (prevention and management) at European level. This will be accomplished by establishing and training national patients’ associations in EU priority countries, creating an EU Electronic Health Record and entering into policy dialogue with policymakers at national and European level.

4. Support research programmes and studies focused on the clinical management of Thalassaemia. This is to be achieved via the publication of guidelines on the clinical management of Thalassaemia, participating in scientific conferences and providing medical specialists in priority countries with fellowships.

Knowledge is our power.

Start date: 01/01/2018 - End date: 31/12/2018

Keywords : [ Advocacy ] [ Awareness Raising ] [ Clinical Management ] [ Disease-Specific Policies ] [ Education ] [ Haemoglobinopathies ] [ Migration ] [ Networking ] [ Prevention ] [ Public Health ] [ Rare Diseases ] [ Research ] [ Thalassaemia ]

Call: Financial contribution to the functioning of non-governmental bodies (Operating grants)

Topic: Public Health

3rd Health Programme (2014-2020)

EUPHA Operating Grant [EUPHA]

The European Public Health Association (EUPHA) is a major player in the European public health area. Since our establishment in 1992, EUPHA has been growing and has an increasing influence on the public health dialogue in Europe.
EUPHA will continue her activities in 2018, fully in line with the 3rd Health Programme of the European Commission. In order to be a leading actor in the public health arena in Europe, we will be introducing a number of new initiatives made possible through the additional funding of the 2018 operating grant. EUPHA identifies the following operational targets for 2018:
1. Strengthening national public health associations;
2. Advocating for public health on the European agenda;
3. Representing the European voice at global level and supporting public health at global level;
4. Providing actively and accurately the evidence to make informed practice and policy decisions in the field of public health;
5. Nurturing the expertise and knowledge on specific public health topics;
6. Preparing the future generation of public health professionals for their leadership role in public health.
EUPHA’s strong organisation, with 25 years of experience, is a solid basis to contribute to the objectives of the Third Health Programme and to play a key role in the European public health area.

Start date: 01/01/2018 - End date: 31/12/2018

Keywords : [ Advocacy ] [ Future Generations ] [ Knowledge And Capacity Building ] [ Public Health ]

Call: Financial contribution to the functioning of non-governmental bodies (Operating grants)

Topic: Public Health